Literature DB >> 12399005

Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats.

David J Rademacher1, Rhea E Steinpreis.   

Abstract

Administration of the non-selective opioid receptor antagonists, naloxone and naltrexone, attenuate the rewarding effects of cocaine. The relative contributions of specific opioid receptor subtypes that underlie this effect have not been well characterized. Administration of 20.0 mg/kg cocaine resulted in a conditioned place preference. Pretreatment with 20.0 mg/kg but neither 10.0 nor 1.0 mg/kg of the selective mu(1)-opioid receptor antagonist, naloxonazine, blocked cocaine-induced conditioned place preference. On the days in which rats received cocaine only, locomotor behavior was elevated. Pretreatment with the selective mu(1)-opioid receptor antagonist, naloxonazine, regardless of dose, had no effect on cocaine-induced hyperlocomotion. These findings indicate that the rewarding effects of cocaine can be blocked solely by mu(1)-opioid receptor antagonism and are consistent with the view that the locomotor and rewarding effects of drugs can be dissociated. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399005     DOI: 10.1016/s0304-3940(02)00950-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 2.  [The endogenous opioid system and drug addiction].

Authors:  R Maldonado
Journal:  Ann Pharm Fr       Date:  2010-01-21

3.  Cocaine place conditioning increases pro-opiomelanocortin gene expression in rat hypothalamus.

Authors:  Y Zhou; A Kruyer; A Ho; M J Kreek
Journal:  Neurosci Lett       Date:  2012-10-13       Impact factor: 3.046

Review 4.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice.

Authors:  Paul Marquez; Ramkumarie Baliram; Ibrahim Dabaja; Nagaraju Gajawada; Kabirullah Lutfy
Journal:  Psychopharmacology (Berl)       Date:  2008-01-06       Impact factor: 4.530

Review 6.  A neuropeptide-centric view of psychostimulant addiction.

Authors:  B Boutrel
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

7.  Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine.

Authors:  Sunmee Wee; Laura Orio; Senait Ghirmai; John R Cashman; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2009-05-30       Impact factor: 4.530

8.  A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat.

Authors:  Joseph A Schroeder; Michele Hummel; Alpha D Simpson; Rizwan Sheikh; Avery R Soderman; Ellen M Unterwald
Journal:  Psychopharmacology (Berl)       Date:  2007-08-09       Impact factor: 4.530

Review 9.  The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Authors:  Kabirullah Lutfy; Nurulain T Zaveri
Journal:  Prog Mol Biol Transl Sci       Date:  2015-12-23       Impact factor: 3.622

10.  The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice.

Authors:  Alexander T Nguyen; Paul Marquez; Abdul Hamid; Brigitte Kieffer; Theodore C Friedman; Kabirullah Lutfy
Journal:  Eur J Pharmacol       Date:  2012-05-02       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.